Related Experiment Video
Updated: Aug 20, 2025

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
Circular RNAs Regulate Vascular Remodelling in Pulmonary Hypertension
Shuang-Lan Xu1, Jie Liu2, Shuang-Yan Xu3
1Department of Respiratory Medicine, The Affiliated Hospital of Yunnan University, The Second People's Hospital of Yunnan Province, Kunming, 650021 Yunnan, China.
Circular RNAs (circRNAs) are novel noncoding RNA molecules involved in disease. This review explores circRNAs
Area of Science:
- Molecular Biology
- Genetics
- Cardiovascular Research
Background:
- Circular RNAs (circRNAs) are a distinct class of noncoding RNA characterized by a unique closed-loop structure.
- These molecules are ubiquitously expressed across various tissues and developmental stages, implicating them in critical pathophysiological processes.
- circRNAs play significant roles in the development and progression of numerous diseases.
Purpose of the Study:
- To review the discovery, characteristics, formation, and biological functions of circRNAs.
- To elucidate the relationship between circRNAs and vascular remodeling.
- To discuss the current research status and potential applications of circRNAs in pulmonary hypertension (PH).
Main Methods:
- Literature review synthesizing existing research on circRNAs.
- Analysis of circRNA involvement in cellular processes relevant to vascular remodeling.
- Evaluation of current studies and future prospects concerning circRNAs in PH.
Main Results:
- circRNAs are integral to the regulation of vascular endothelial and smooth muscle cell remodeling.
- A growing body of evidence links circRNAs to the pathogenesis of pulmonary hypertension.
- circRNAs demonstrate significant potential for diagnostic and therapeutic applications in PH.
Conclusions:
- circRNAs are closely associated with vascular remodeling processes relevant to PH.
- Further investigation into circRNAs' role in PH pathogenesis offers promising avenues for research.
- Understanding circRNAs can advance the screening, diagnosis, prevention, and treatment of PH.
More Related Videos
09:23Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
10:20Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice
Published on: January 16, 2013
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Vascular Resistance
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Heart Failure II: Pathophysiology